Table 2. Vaccination status by age group in a subset of the study population, France, October 2024–February 2025 (n = 54,607)a .
| Vaccine | Age groups in years | |||||||
|---|---|---|---|---|---|---|---|---|
| 18–64, n = 31,856 | 0–4 n = 4,191 |
5–17 n = 5,929 |
≥ 65 n = 12,631 |
|||||
| Number | % | Number | % | Number | % | Number | % | |
| No vaccine | 29,359 | 92 | 4,148 | 99 | 5,839 | 98 | 7,335 | 58 |
| Vaccine < 15 days | 416 | 1.3 | 9 | 0.2 | 19 | 0.3 | 727 | 5.8 |
| Vaccine 15 days–3 months | 2,081 | 6.5 | 34 | 0.8 | 71 | 1.2 | 4,569 | 36 |
a People vaccinated over 3 months prior to testing (n = 4,865) are not considered in the table.